DEPLOYDatabase

Partnership

Stryker acquisition of Vocera Communications

Stryker Corporation acquired Vocera Communications for 79.25 USD per share, total enterprise value of approximately 3.09B USD. The acquisition brought Vocera's clinical communication and workflow technology into Stryker's medical division. The deal closed in Q1 2022.

investment · Concluded · operating


Machine-readable surfaces

cbb85ee8-9ca2-4c21-a072-864614f847b8
Type
investment
Status
Concludedoperating
Announced
2022-01-06
4.7 years ago
Start
2022-02-01
4.6 years ago
Active for
4.6 years

Who’s involved

Vocera Communicationstechnology provider

Vocera Communications, now part of [Stryker](https://www.stryker.com), developed hands-free wearable communication devices for healthcare, including the Vocera Badge — a Wi-Fi-enabled, voice-activated wearable that connects clinicians by name, role, or group. Founded in 2000, the company pioneered voice-over-Wi-Fi communication in hospitals and expanded into clinical workflow software, alarm management, and patient engagement tools. Stryker acquired Vocera in February 2022 for approximately 3.1 billion USD

HQSan Jose, CA1 partnerships

Most-frequent partners

Strykerinvestor partner

Stryker Corporation (NYSE: SYK) is one of the [World](/companies/world-labs)'s largest medical technology companies, headquartered in Kalamazoo, Michigan, with $25B in 2025 revenue and approximately 56,000 employees. The company's Mako SmartRobotics platform is the leading robotic orthopedic surgery system, with record Mako installations in 2024 for hip and knee replacements, and the next-generation Mako showcased at AAOS 2025 including the new Mako Shoulder application.

HQKalamazoo, MI, USAstryker.com4 partnerships

Related partnerships

Recent partnerships of the same kind

Sources (1)

  1. https://investors.stryker.com/press-releases/news-details/2022/Stryker-announces-definitive-agreement-to-acquire-Vocera-Communications/default.aspx

Deploy Watch

Track this partnership.

We notify you when the status changes against primary-source evidence, expansion is verified, or the partnership is terminated.